Delivery Order SPE2DR25D2206-SPE2DR26F9DF4
- Not listed
- The Defense Logistics Agency awarded a $19,657.60 delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Actemra 400 mg/20 ml vials. This is a firm fixed-price, competitively awarded contract with a completion date of November 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is a child contract executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,597.56 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Actemra 400 mg/20 mL vials. This competitively awarded, non-set-aside contract will be completed by October 29, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $10,744.05 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 ml syringes on November 4, 2025, with completion expected by November 5, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $77,052.87 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply support to federal healthcare...
- On September 19, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $38,572.76 to supply Actemra 200 mg/10 mL vials. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of September 22, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $8,243.54 delivery order to AmerisourceBergen Drug Corp for 4,569,930,973 units of Actemra 400 mg/20 ml vials. This is a non-set-aside, competitively awarded firm fixed-price delivery order with a completion date of November 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,816.36 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 200 mg/10 mL vials on December 2, 2025, with an ultimate completion date of December 3, 2025. This non-competitive, firm fixed-price delivery order represents a single-line pharmaceutical procurement executed under a competitive award mechanism. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $11,336.48 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 ml syringes, with a completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a direct fulfillment order under AmerisourceBergen's broader contract vehicle with DLA. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Actemra 400 mg/20 mL vials with a ceiling value of $6,630.33. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of June 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,939.02 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, utilizes firm fixed price pricing with no set-aside designation, indicating competitive award through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9DF4Delivery Order
The Defense Logistics Agency awarded a $28,150.37 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 ml vials. This competitively awarded, firm fixed-price contract was issued on November 25, 2025, with an ultimate completion date of November 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor agreement enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's significant presence as a major pharmaceutical distributor and its consistent track record of competitive awards demonstrate its capability to meet federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.2k | 11/24/25 |